NDCs: The Same "Middle 4" Does Not Mean Equal

September 01, 2008

Medication Safety

Verifying prescriptions by checking the National Drug Code's 4-digit product identifier is not enough; duplication of these "middle 4" numbers can cause product mix-ups in pharmacies.

Drug Diversion and Abuse: The Future of Analgesic Drugs

September 01, 2008

Legal Focus

Safe and effective treatment options, such as analgesics, are available for pain management; however, their potential for abuse has risen in the past few years—pharmacists play a key role in reducing diversion.

Crohn's Disease%u2014Strategies to Improve Quality of Life

September 01, 2008

Counseling Focus

Crohn's disease, an inflammatory bowel disease, has no cure; the primary goal of therapy is to improve quality of life by minimizing gastrointestinal and extraintestinal complications of the disease.

2-Minute Consultation: Target Hyperlipidemia

September 01, 2008

Health Systems Pharmacy

Hyperlipidemia is one of the most treatable causes of coronary artery disease. This toolkit for pharmacists will help patients design a cholesterol-lowering program, armed with the right medications and the right information.

A Pharmacist's Guide to OTC Therapy: Osteoarthritis

September 01, 2008

OTC Focus

The 2 main causes of joint pain are osteoarthritis and rheumatoid arthritis. Osteoarthritis may be treated with self-therapy—several recommendations and product choices are reviewed here.

Get to Know an Enzyme: CYP3A4

September 01, 2008

Drug Interactions

The last in the series of cytochrome P450 enzyme articles ends with the most important enzyme-CYP3A4, which metabolizes approximately half of all the drugs on the market.